Listeria monocytogenes Brain Abscess: Controversial Issues for the Treatment—Two Cases and Literature Review. (24th July 2018)

• Record Type: Journal Article
• Authors: Tiri, Beatrice; Priante, Giulia; Saraca, Lavinia Maria; Martella, Lucia Assunta; Cappanera, Stefano; Francisci, Daniela
• Other Names: Shibata Tomoyuki Academic Editor.
• Is Part Of: Case reports in infectious diseases. Volume 2018(2018)
• Publication Date: 2018-07-24
• Subjects: Communicable diseases -- Periodicals; Communicable diseases -- Case studies -- Periodicals; Communicable Diseases; Infectious Disease Medicine; Communicable diseases; Electronic journals; Periodicals; Case studies; Periodicals; 616.9
• DOI: 10.1155/2018/6549496
• Languages: English
• ISSNs: 2090-6625

Abstract

Abstract : Listeria monocytogenes (LM) is an opportunistic pathogen, and the most common central nervous system manifestation is meningitis while listerial brain abscesses are rare. We describe 2 cases of brain abscess due to LM and a literature review. Only 73 cases were reported in the literature from 1968 to 2017. The mean age was 51.9, and the mortality rate was 27.3%. In 19% of cases, no risk factors for neurolisteriosis were identified. Blood cultures were positive in 79.5% while CSF or brain abscess biopsy material was positive in 50.8%. In 40% was started a monotherapy regimen while in 60% a combination therapy without substantial differences in mortality. Fifty-two percent underwent neurosurgery while 45.3% has been treated only with medical therapy. The mortality rates were, respectively, 13% and 38.2%. Only 25% of patients who were treated for ≤6 weeks underwent neurosurgery, while 80% of those who were treated for ≥8 weeks were operated. The mortality rates were, respectively, 12.5% and 0%, suggesting that a combined approach of surgery and prolonged medical therapy would have an impact on mortality. We believe that it is essential to carry out this review as brain abscesses are rare, and there are no definitive indications on the optimal management, type, and duration of therapy.